enoxacin has been researched along with Prostatic Hyperplasia in 8 studies
Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Enoxacin was administered at the daily dosage of 300 mg every 12 hours for 10 days." | 6.67 | [Enoxacin in the treatment of asymptomatic bacteriuria in patients with prostatic adenoma]. ( Beghelli, R; Cortecchia, W; D'Amato, G; Dal Pra, ML; Emili, E; Frigola, M; Lo Cigno, M; Soli, M, 1991) |
| "Enoxacin was administered at the daily dosage of 300 mg every 12 hours for 10 days." | 2.67 | [Enoxacin in the treatment of asymptomatic bacteriuria in patients with prostatic adenoma]. ( Beghelli, R; Cortecchia, W; D'Amato, G; Dal Pra, ML; Emili, E; Frigola, M; Lo Cigno, M; Soli, M, 1991) |
| "Enoxacin was administered orally at a dose of 200 mg, three times 2 days and one day before and once on the day of the operation." | 1.28 | [A study on enoxacin concentration in human prostatic tissue]. ( Kataumi, Z; Kitamura, Y; Nakamura, T; Takeda, H, 1990) |
| "Enoxacin is a new quinolone derivative that is well absorbed after oral administration and shows good efficacy against the pathogenic bacteria usually isolated in urinary infections." | 1.28 | In vivo diffusion of enoxacin in healthy renal and adenomatous prostate tissue in man. ( Charton, M; Timbal, Y, 1990) |
| "Enoxacin was administered orally at a dose of 200 mg, three times one day before and twice on the day of operation." | 1.27 | [Enoxacin concentration in human prostatic tissue]. ( Asakawa, M; Kobayakawa, H; Yasumoto, R, 1986) |
| "Enoxacin was administered orally in a dose of 200 mg three times daily for 3 days preoperatively." | 1.27 | [Enoxacin concentration in human prostatic tissue after 3-day administration]. ( Hasuda, A; Kato, M; Kuji, S; Morita, M, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kitamura, Y | 1 |
| Kataumi, Z | 1 |
| Nakamura, T | 1 |
| Takeda, H | 1 |
| Charton, M | 1 |
| Timbal, Y | 1 |
| Cortecchia, W | 1 |
| Beghelli, R | 1 |
| Frigola, M | 1 |
| Soli, M | 1 |
| Lo Cigno, M | 1 |
| Emili, E | 1 |
| D'Amato, G | 1 |
| Dal Pra, ML | 1 |
| Rannikko, S | 1 |
| Malmborg, AS | 1 |
| Yasumoto, R | 1 |
| Kobayakawa, H | 1 |
| Asakawa, M | 1 |
| Desai, KM | 1 |
| Abrams, PH | 1 |
| White, LO | 1 |
| Morita, M | 1 |
| Kato, M | 1 |
| Kuji, S | 1 |
| Hasuda, A | 1 |
| Naber, KG | 1 |
| Sörgel, F | 1 |
| Kees, F | 1 |
| Schumacher, H | 1 |
| Sigl, G | 1 |
| Zürcher, J | 1 |
| Berger, S | 1 |
2 trials available for enoxacin and Prostatic Hyperplasia
| Article | Year |
|---|---|
[Enoxacin in the treatment of asymptomatic bacteriuria in patients with prostatic adenoma].
Topics: Aged; Bacteriuria; Drug Evaluation; Enoxacin; Humans; Male; Middle Aged; Prostatic Hyperplasia | 1991 |
A double-blind comparative trial of short-term orally administered enoxacin in the prevention of urinary infection after elective transurethral prostatectomy: a clinical and pharmacokinetic study.
Topics: Adult; Aged; Anti-Infective Agents, Urinary; Clinical Trials as Topic; Double-Blind Method; Enoxacin | 1988 |
6 other studies available for enoxacin and Prostatic Hyperplasia
| Article | Year |
|---|---|
[A study on enoxacin concentration in human prostatic tissue].
Topics: Aged; Aged, 80 and over; Enoxacin; Humans; Male; Middle Aged; Premedication; Prostate; Prostatic Hyp | 1990 |
In vivo diffusion of enoxacin in healthy renal and adenomatous prostate tissue in man.
Topics: Aged; Chromatography, High Pressure Liquid; Enoxacin; Humans; Kidney; Male; Middle Aged; Nephrectomy | 1990 |
Enoxacin concentration in human prostatic tissue after oral administration.
Topics: Administration, Oral; Enoxacin; Humans; Male; Naphthyridines; Prostate; Prostatic Hyperplasia | 1986 |
[Enoxacin concentration in human prostatic tissue].
Topics: Administration, Oral; Anti-Infective Agents; Enoxacin; Humans; Male; Naphthyridines; Prostate; Prost | 1986 |
[Enoxacin concentration in human prostatic tissue after 3-day administration].
Topics: Administration, Oral; Aged; Anti-Infective Agents, Urinary; Drug Administration Schedule; Enoxacin; | 1988 |
[Enoxacin concentration in seminal fluid, in prostate secretions and in prostatic adenoma tissue following oral administration or intravenous infusion].
Topics: Administration, Oral; Adult; Aged; Body Fluids; Enoxacin; Humans; Infusions, Intravenous; Male; Midd | 1989 |